Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 31 articles: HTML format

Single Articles

June 2026
1. DU TOIT G, Lack G
   Prevention and Treatment of Peanut Allergy.
   N Engl J Med. 2026;394:2449-2458.
   PubMed     Abstract available
   
   
   November 2025
2. BOYCE JA
   A New Stage for Seasoned Actors - Food Anaphylaxis and the Cysteinyl Leukotrienes.
   N Engl J Med. 2025;393:2054-2057.
   PubMed    
   
   
   October 2025
3. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
   Common Diseases in Clinical Cohorts - Not Always What They Seem.
   N Engl J Med. 2025;393:1589-1598.
   PubMed     Abstract available
   
   
   
4. MARWAH H, Ramsey A, Macy EM
   Allergy or Assumption of Allergy - When to Test for a Penicillin Allergy.
   N Engl J Med. 2025;393:1340-1342.
   PubMed    
   
   
   July 2025
5. KAHLMANN V, Janssen Bonas M, Moor CC, Grutters JC, et al
   First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.
   N Engl J Med. 2025;393:231-242.
   PubMed     Abstract available
   
   
   May 2025
6. LAFORCE C, Albers F, Danilewicz A, Jeynes-Ellis A, et al
   As-Needed Albuterol-Budesonide in Mild Asthma.
   N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544.
   PubMed     Abstract available
   
   
   March 2025
7. METZ M, Gimenez-Arnau A, Hide M, Lebwohl M, et al
   Remibrutinib in Chronic Spontaneous Urticaria.
   N Engl J Med. 2025;392:984-994.
   PubMed     Abstract available
   
   
   January 2025
8. COHN DM, Gurugama P, Magerl M, Katelaris CH, et al
   CRISPR-Based Therapy for Hereditary Angioedema.
   N Engl J Med. 2025;392:458-467.
   PubMed     Abstract available
   
   
   September 2024
9. ROTHENBERG ME, Dellon ES, Collins MH
   Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
   N Engl J Med. 2024;391:1067-1068.
   PubMed    
   
   
   
10. CHEHADE M, Dellon ES, Spergel JM
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2024;391:1066-1067.
    PubMed    
    
    
    
11. MENNINI M, Parisi P, Di Nardo G
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1066.
    PubMed    
    
    
    
12. LIN CH
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065-1066.
    PubMed    
    
    
    
13. CHAO CY, Chao HH, Yong SB
    Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
    N Engl J Med. 2024;391:1065.
    PubMed    
    
    
    
14. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma. Reply.
    N Engl J Med. 2024;391:968.
    PubMed    
    
    
    
15. VAN GEFFEN WH, van der Meer AN
    Early Diagnosis and Treatment of COPD and Asthma.
    N Engl J Med. 2024;391:967-968.
    PubMed    
    
    
    
16. YANG J, Liu W
    Angioedema of the Intestines.
    N Engl J Med. 2024;391:941.
    PubMed    
    
    
    
17. JACKSON DJ, Wechsler ME, Jackson DJ, Bernstein D, et al
    Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
    N Engl J Med. 2024 Sep 9. doi: 10.1056/NEJMoa2406673.
    PubMed     Abstract available
    
    
    July 2024
18. PETERS NE, Mac Lochlainn DJ, Dhalla F, Howarth L, et al
    Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
    N Engl J Med. 2024;391:56-59.
    PubMed     Abstract available
    
    
    
19. RIEDL MA, Farkas H, Aygoren-Pursun E, Psarros F, et al
    Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
    N Engl J Med. 2024;391:32-43.
    PubMed     Abstract available
    
    
    
20. AMERATUNGA R, Longhurst HJ
    New Therapies for Type 1 and Type 2 Hereditary Angioedema.
    N Engl J Med. 2024;391:79-81.
    PubMed    
    
    
    
21. RIEDL MA, Tachdjian R, Lumry WR, Craig T, et al
    Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
    N Engl J Med. 2024;391:21-31.
    PubMed     Abstract available
    
    
    June 2024
22. WRIGHT BL
    Unmasking the Culprits in Eosinophilic Esophagitis Pathogenesis.
    N Engl J Med. 2024;390:2321-2322.
    PubMed    
    
    
    
23. ROTHENBERG ME, Dellon ES, Collins MH, Bredenoord AJ, et al
    Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
    N Engl J Med. 2024;390:2252-2263.
    PubMed     Abstract available
    
    
    
24. CHEHADE M, Dellon ES, Spergel JM, Collins MH, et al
    Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
    N Engl J Med. 2024;390:2239-2251.
    PubMed     Abstract available
    
    
    May 2024
25. WOOD RA, Togias A, Chinthrajah RS
    Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    N Engl J Med. 2024;390:1936.
    PubMed    
    
    
    
26. HUI SHI EN E, Cheng-Chung Wei J
    Omalizumab for the Treatment of Multiple Food Allergies.
    N Engl J Med. 2024;390:1936.
    PubMed    
    
    
    
27. AARON SD, Vandemheen KL, Whitmore GA, Bergeron C, et al
    Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.
    N Engl J Med. 2024 May 19. doi: 10.1056/NEJMoa2401389.
    PubMed     Abstract available
    
    
    
28. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed    
    
    
    February 2024
29. WANG S, Dai H
    Crazy-Paving Pattern in Pulmonary Sarcoidosis.
    N Engl J Med. 2024;390:e21.
    PubMed    
    
    
    
30. WOOD RA, Togias A, Sicherer SH, Shreffler WG, et al
    Omalizumab for the Treatment of Multiple Food Allergies.
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMoa2312382.
    PubMed     Abstract available
    
    
    
31. WONG GWK
    Options for Multiple Food Allergies - Food Avoidance or Pharmacologic Treatment?
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMe2400807.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum